An official website of the United States government
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.
When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.
Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.
Summary: CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. The purpose of this amendment is to establish a COVID-19 interim payment methodology for primary care medical providers (PCMP) who provide integrated services.
Summary: Updates and corrects the assurances selected related to utilization review to indicate that the Department undertakes utilization review requirements through a contract with a utilization and Quality Improvement Organization (QIO) or QIO-Like Entity.
Summary: Changes from paying licensed pharmacists individually for Medication Therapy Counseling to contracting with an entity to run the program, and updates program requirements and restrictions.
Summary: Proposes to update the pharmaceutical rate methodology by including National Average Drug Acquisition (NADAC) and Maximum Allowable Cost (MAC) into the lesser of logic methodology.
Summary: Decreases clinical diagnostic laboratory rates on a per-test basis to align with Medicare rates in accordance with the Social Security Act Section 1903(i)(7)
Summary: This time-limited state plan amendment responds to the COVID-19 national emergency. The purpose of this amendment is to provide flexibilities in the areas of home health, transportation, telemedicine, inpatient hospital services, and pharmacy benefits.